Lumos Pharma, Inc.

NASDAQ:LUMO

3.92 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008
Assets:
Current Assets:
Cash & Cash Equivalents 35.07856.00794.80998.67990.549120.738158.708131.49195.62190.40461.29120.2539.4910.57215.2176.276
Short Term Investments 0.99911.3520000002.1812.3930.2491.4942.492.26900
Cash and Short Term Investments 36.07767.35994.80998.67990.549120.738158.708131.49197.8202.79761.5421.74439.4912.84115.2176.276
Net Receivables 0.210.2230.12826.2640.8240.79810.5325.9755.38815.6041.6570.7380.3990.8421.5790.595
Inventory 00000000-5.3883.7290-0.7380.40900.110.05
Other Current Assets 3.7484.4274.743.5063.0465.5366.22630.44710.3428.3330.7731.6452.490.9591.9921.85
Total Current Assets 40.03572.00999.677128.44994.419127.072175.466167.912208.142230.46363.9723.38942.78814.64218.8988.771
Non-Current Assets:
Property, Plant & Equipment, Net 0.6030.2830.6350.5842.3683.7275.0916.83510.47.5996.5876.045.5915.4362.9190.955
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 000000.140.14000000000
Tax Assets 00000000015.604000000
Other Non-Current Assets 0-0.283-0.635-0.58400000-15.60400000.850.85
Total Non-Current Assets 0.6030.2830.6350.5842.3683.8675.2316.83510.47.5996.5876.045.5915.4363.7691.805
Total Assets 40.63872.292100.312129.03396.787130.939180.697174.747218.542238.06270.55729.42948.37920.07822.66710.576
Liabilities & Equity:
Current Liabilities:
Account Payables 0.890.2750.6120.2440.4750.5559.25622.88312.4222.4123.4730.9721.670.5521.080.601
Short Term Debt 0.2820.2330.3520.3191.1430.0610.160.2320.5710.1920.1890.2046.2140.2070.0350.004
Tax Payables 00000.0110000.85900.31900000
Deferred Revenue 0000000.0560.3910.89212.9660.0840.08400.9510.9471.237
Other Current Liabilities 5.8586.24.1665.89810.2098.23112.55914.3990.9559.5320.131.6592.781.5551.1790.006
Total Current Liabilities 7.036.7085.136.46111.8278.84722.03137.90514.8425.1023.8762.91910.6643.2653.2411.848
Non-Current Liabilities:
Long Term Debt 660.20560.0820.0430.1110.2850.3680.867.0337.1780.9427.0876.0786.004
Deferred Revenue Non-Current 000000.9060.9981.0910.4071.0851.3211.405-0.642000
Deferred Tax Liabilities Non-Current 000000001.1531.2380.0460.0380.094000
Other Non-Current Liabilities 0.303060666666-0.046-0.0380.54861.74554.13434.554
Total Non-Current Liabilities 6.30366.20566.0826.9497.1097.3767.9289.1838.3548.5830.94268.83260.21240.558
Total Liabilities 13.33312.70811.33512.46117.90915.79629.1445.28122.76834.28512.2311.50211.60672.09763.45342.406
Equity:
Preferred Stock 000129.03363.53560.49557.4540000001.031.031.03
Common Stock 0.0810.0820.0830.0830.3740.3730.3720.2920.2880.280.2660.210.2060.0360.0670.066
Retained Earnings -161.517-127.483-96.421-65.991-334.001-291.012-237.459-165.508-80.353-33.119-135.977-104.797-81.476-63.389-46.962-37.52
Accumulated Other Comprehensive Income/Loss -0-0.0090-129.033-63.535-6.985-6.638-5.726-6.5160000-2.224-1.569-1.266
Other Total Stockholders Equity 188.741186.994185.315182.48412.505352.272337.828300.408282.355236.616194.038122.514118.0439.5854.2963.318
Total Shareholders Equity 27.30559.58488.977116.57278.878115.143151.557129.466195.774203.77758.32717.92736.773-54.962-43.138-34.372
Total Equity 27.30559.58488.977116.57278.878115.143151.557129.466195.774203.77758.32717.92736.773-52.019-40.786-31.83
Total Liabilities & Shareholders Equity 40.63872.292100.312129.03396.787130.939180.697174.747218.542238.06270.55729.42948.37920.07822.66710.576